Torrent Pharmaceuticals Limited vs Wockhardt Limited

A side-by-side comparison of Torrent Pharmaceuticals Limited (TORNTPHARM) and Wockhardt Limited (WOCKPHARMA) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, Torrent Pharmaceuticals Limited leads TORNTPHARM vs WOCKPHARMA on 11 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation31
  • Profitability40
  • Growth10
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

TORNTPHARM takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

71.32
P/E ratio
149.00
22.29
P/B ratio
7.30
0.77%
Dividend yield
0.00%
₹63.92
EPS
₹13.12

Profitability

TORNTPHARM takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

25.78%
Return on equity
4.31%
13.91%
Return on capital
6.35%
32.61%
EBITDA margin
19.33%
15.29%
Net margin
5.90%

Growth

TORNTPHARM takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.27%
Revenue CAGR (3Y)
8.36%
19.75%
Profit CAGR (3Y) even
—

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.73L Cr
Market cap
₹31,673 Cr
₹13,980 Cr
Revenue
₹3,373 Cr
₹2,138 Cr
Net profit
₹199 Cr
1.79
Debt / equity
0.44
Torrent Pharmaceuticals Limited
  • + ["Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 67.6%"]
  • − ["Stock is trading at 20.67 times its book value", "Company has a high debt to equity ratio of 1.79."]
Wockhardt Limited
  • + []
  • − ["Stock is trading at 6.41 times its book value", "The company has delivered a poor sales growth of 4.5% over past five years.", "The company has delivered a poor profit growth of -22.0% over past five years.", "Company has a low return on equity of -3.8% over last 3 years."]
Torrent Pharmaceuticals Limited full analysis Wockhardt Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

TORNTPHARM vs WOCKPHARMA: Share Price, Valuation & Which to Buy | DocStoX